Abstract Details
Thomas Brannagan III, MD, FAAN
(Columbia University)
PRESENTER |
Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL. Dr. Brannagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam. The institution of Dr. Brannagan has received research support from Alnylam. The institution of Dr. Brannagan has received research support from Acceleron. The institution of Dr. Brannagan has received research support from Ionis. The institution of Dr. Brannagan has received research support from Pharnext. |
Marcia Waddington Cruz, MD (Hospital Universitario) | Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sobi. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Waddington Cruz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. |
Annabel K. Wang, MD, FAAN (VA Long Beach Healthcare System) | Dr. Wang has nothing to disclose. |
Michael J. Polydefkis, MD, FAAN (Johns Hopkins University School of Medicine) | Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceutical . Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Polydefkis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. |
Peter J. Dyck, MD, FAAN (Mayo Clinic) | Dr. Dyck has nothing to disclose. |
Sami L. Khella, MD, FAAN (Presbyterian Med Ctr/Dept of Neuro) | Dr. Khella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Khella has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. |
Violaine Plante-Bordeneuve, MD (CHU Henri Mondor) | Dr. Plante-Bordeneuve has nothing to disclose. |
John L. Berk | John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca/IONIS. John L. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eidos/BridgBio. John L. Berk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia Therapeutics. John L. Berk has received research support from Alnylam . John L. Berk has received research support from Ionis. John L. Berk has received research support from Eidos/Bridgbio. |
Fabio Adrian Barroso, MD | Fabio Adrian Barroso, MD has nothing to disclose. |
No disclosure on file | |
Isabel Conceicao (Hospital de Santa Maria) | Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Isabel Conceicao has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sobi. |
Steven G. Hughes | Steven G. Hughes has received personal compensation for serving as an employee of Avidity Biosciences. Steven G. Hughes has received personal compensation for serving as an employee of Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ionis Pharmaceuticals. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avidity Biosciences. Steven G. Hughes has stock in Arcturus Therapeutics. Steven G. Hughes has stock in Avidity Biosciences. |
No disclosure on file | |
No disclosure on file | |
Spencer Guthrie | No disclosure on file |
No disclosure on file | |
Merrill Benson | No disclosure on file |
No disclosure on file | |
Teresa Coelho, MD (Unidate Clinica de Paramoloidose Hospital) | Dr. Coelho has nothing to disclose. |